Question 1

Has Kenneth Weisiger received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $11,342 in general payments to Kenneth Weisiger across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Kenneth Weisiger did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Kenneth Weisiger come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Mylan Specialty L.p.	30	$8,814
GSK	27	$906
Grifols USA, LLC	35	$525
Sunovion Pharmaceuticals Inc.	14	$235
AstraZeneca	9	$209
Pulmonx Corporation	1	$115
Electromed, Inc.	7	$113
Inspire Medical Systems, Inc.	2	$79
Inogen, Inc.	3	$48
Takeda Pharmaceuticals U.S.A., Inc.	2	$45
Advanced Respiratory, Inc	2	$41
Nestle Healthcare Nutrition Inc.	2	$36
Philips North America LLC	2	$34
Circassia Inc.	2	$32
Avadel CNS Pharmaceuticals, LLC	1	$23
Breathe Technologies, Inc.	1	$21
ANI Pharmaceuticals, Inc.	1	$20
Mallinckrodt Enterprises LLC	1	$19
Jazz Pharmaceuticals Inc.	1	$15
Resmed Corp	1	$12

Kenneth Weisiger

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other pulmonary disease in Lakewood